Does preterm birth increase the initiation of antidepressant use during the postpartum? A population-based

Giovanna Esposito1, Anna Cantarutti2,3, Angela Lupattelli4

  • 1Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

PubMed

Insights

Women who deliver preterm babies face a higher risk of starting antidepressant use within a year postpartum. This increased risk is significant for all preterm births, especially extremely preterm deliveries.

Area of Science:

  • Perinatal mental health research
  • Reproductive health epidemiology
  • Psychiatric pharmacovigilance

Background:

  • Preterm birth is a significant obstetric complication with potential long-term impacts on maternal well-being.
  • Maternal mental health, particularly postpartum, is a critical area of concern following childbirth.
  • The association between preterm birth and the initiation of antidepressant use requires further investigation.

Purpose of the Study:

  • To investigate the relationship between preterm birth and the subsequent risk of initiating antidepressant use.
  • To quantify the risk of antidepressant initiation in mothers experiencing preterm births.
  • To explore how the timing of preterm birth influences the risk of postpartum antidepressant use.

Main Methods:

  • A population-based study utilizing regional healthcare utilization databases.
  • Inclusion of over 727,000 deliveries between 2010 and 2020 in Lombardy, Northern Italy.
  • Log-binomial regression analysis to estimate relative risks (RR) and 95% confidence intervals (CI), adjusting for key maternal and delivery factors.

Main Results:

  • Preterm birth was associated with a 38% increased risk of initiating antidepressant use (aRR=1.38) for moderate to late preterm births.
  • Extremely and very preterm births showed an 83% increased risk of antidepressant initiation (aRR=1.83).
  • These associations remained consistent after excluding women with single prescriptions or those using other psychotropic drugs.

Conclusions:

  • Women with preterm deliveries exhibit an elevated risk of initiating antidepressant use in the first year postpartum.
  • The findings highlight a critical need for enhanced mental health support for mothers of preterm infants.
  • This study underscores the importance of considering preterm birth as a risk factor for postpartum depression and anxiety requiring pharmacological intervention.
Abstract

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
380
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
466
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
176
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
134